TrialJournal of clinical hypertension (Greenwich, Conn.)2022

Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trial.

Ki-Chul Sung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.